市场活动

查看全部
    海报下载丨百奥赛图与您分享AACR 20张海报研究成果,回顾展台亮点

    海报下载丨百奥赛图与您分享AACR 20张海报研究成果,回顾展台亮点

    April 16, 2024
    Share on:



    2024年4月7-10日,百奥赛图在美国圣地亚哥参加2024年美国癌症研究协会(AACR)年会,期间展示了20张海报,包括9项全人单抗、双抗、双抗ADC、类TCR抗体药物分子最新数据和11项临床前动物模型及药理药效研究的最新成果。



    Modality

    Abstract Number

    Poster Title

    mAb

    LB130

    Identification of fully human CCR8 antibodies that demonstrate excellent ADCC function, potent blocking activity, and robust anti-tumor immune responses

    TCRm

    6717

    Targeting mutant KRAS proteins with novel TCR-mimic fully human antibodies

    bsAb

    2724

    BCG020, a novel bispecific antibody targeting EGFR and CD70, is effective against EGFR and CD70 high expressed tumors

    bsADC

    2620

    BCG016, a first-in-class bispecific antibody-drug conjugate targeting 5T4 and MUC1, demonstrates potent preclinical anti-tumor activity

    2618

    BCG017, a bispecific ADC targeting PTK7 and EGFR exhibits anti-tumor efficacy in PDX models

    2619

    A novel EGFR×HER3-targeting bispecific antibody drug-conjugate, BCG019, demonstrates robust anti-tumor efficacy in preclinical evaluation

    2617

    BCG022, a novel HER3×MET bispecific antibody-drug conjugate (bsADC), demonstrates promising anti-tumor efficacy

    LB127

    A first-in-class bispecific ADC targeting FOLR1 and MUC1 exhibits promising anti-tumor activity in a FOLR1low xenograft model

    2616

    BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts



    Abstract Number

    Model(s)

    Poster Title

    113

    B-hIL31/hIL31RA/hOSM/hOSMR mice

    Generation and validation of a novel humanized IL-31/IL-31RA/OSM/OSMR mouse model

    116

    B-hPD-1/hPD-L1/hCD94/hNKG2A mice

    Generation of humanized PD-1/PD-L1/CD94/NKG2A mice for evaluating novel combination therapies

    123

    B-hCD3EDG/h4-1BB mice

    Establishment of humanized CD3EDG/4-1BB mice for testing novel T cell engagers

    124

    B-hTL1A mice

    Validation of humanized TL1A mice for advancing preclinical research

    125

    B-hVEGFA mice

    Development of humanized VEGFA models to assess preclinical efficacy of novel therapeutics in vivo

    5339

    B-hIL5/hIL5RA mice

    Establishment of a humanized IL5/IL5RA mouse model to evaluate modulators of eosinophilic inflammation in vivo

    5345



    Development and validation of humanized HLA mouse model platforms for preclinical evaluation of novel peptide vaccines

    5346

    B-hCD16A (CB-17 SCID) mice

    A novel humanized CD16A model to evaluate efficacy of human antibody therapeutics in triggering ADCC

    LB363

    B-hNKP46 mice

    A novel humanized NKP46 mouse model to support xenograft studies evaluating NK cell-based cancer immunotherapies

    LB365

    B-SDG rats

    Generation of a novel severely immunodeficient Sprague Dawley rat model for xenograft studies

    1531



    TIL analysis demonstrates different mechanisms underlying PD-1 resistance in animal models